2514
Quantifying Th2 Immunomodulation in Clinical Trials
Saturday, February 21, 2015: 12:30 PM-1:30 PM
Hilton Americas, Level Four, Lanier Grand Ballroom K
1.00 CME/ 1.20 CE
Primary Discussion Leaders:
Calman Prussin , MD FAAAAI
Erik R. Wambre , PhD MBE

Learning Objectives

  1. Describe the utility of measuring Th2 responses as a surrogate marker for immunomodulatory therapy
  2. Describe and discuss the different techniques available to measure total and allergen-specific Th2 responses
  3. Identify and apply these techniques to clinical trials of allergen immunotherapy and immunomodulator therapy
See more of: Seminar